An Open-Label, Single-Arm, Multicenter, Prospective, Post-Marketing Study to Evaluate the Effectiveness and Safety of Fluticasone Furoate/Vilanterol (FF/VI) Dry Powder Inhaler (DPI) in the Management of Asthma Patients (PROMISE-OD)
一项开放标签、单臂、多中心、前瞻性、上市后研究，旨在评估糠酸氟替卡松/维兰特罗（FF/VI）干粉吸入剂（DPI）在哮喘患者治疗中的有效性和安全性（PROMISE-OD）
期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.104295
Kumar, Ankit; Gupta, Sandeepkumar; Jhawar, Punit K; Raparthy, Suresh; Sahoo, Satyajeet; Raghumanda, Sunil Kumar; Bhojwani, Divya; Bhagat, Sagar; Bhushan, Sumit; Patil, Saiprasad; Barkate, Hanmant
